Halozyme Therapeutics, Inc. (HALO)
107.00
0.00 (0.00%)
USD |
NASDAQ |
Sep 11, 14:42
Halozyme Therapeutics Gross Profit (TTM) : 1.271B for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.271B |
| March 31, 2026 | 1.160B |
| December 31, 2025 | 1.091B |
| September 30, 2025 | 979.74M |
| June 30, 2025 | 921.38M |
| March 31, 2025 | 833.77M |
| December 31, 2024 | 784.86M |
| September 30, 2024 | 706.65M |
| June 30, 2024 | 624.62M |
| March 31, 2024 | 603.77M |
| December 31, 2023 | 563.12M |
| September 30, 2023 | 537.96M |
| June 30, 2023 | 531.56M |
| March 31, 2023 | 485.44M |
| December 31, 2022 | 477.66M |
| September 30, 2022 | 423.26M |
| June 30, 2022 | 386.03M |
| March 31, 2022 | 392.45M |
| December 31, 2021 | 361.90M |
| September 30, 2021 | 376.91M |
| June 30, 2021 | 339.42M |
| March 31, 2021 | 275.46M |
| December 31, 2020 | 224.23M |
| September 30, 2020 | 165.77M |
| June 30, 2020 | 129.92M |
| Date | Value |
|---|---|
| March 31, 2020 | 116.71M |
| December 31, 2019 | 149.45M |
| September 30, 2019 | 167.08M |
| June 30, 2019 | 168.11M |
| March 31, 2019 | 166.21M |
| December 31, 2018 | 141.73M |
| September 30, 2018 | 269.19M |
| June 30, 2018 | 299.66M |
| March 31, 2018 | 291.26M |
| December 31, 2017 | 285.46M |
| September 30, 2017 | 134.39M |
| June 30, 2017 | 101.71M |
| March 31, 2017 | 100.77M |
| December 31, 2016 | 113.48M |
| September 30, 2016 | 126.28M |
| June 30, 2016 | 118.16M |
| March 31, 2016 | 128.38M |
| December 31, 2015 | 105.81M |
| September 30, 2015 | 86.24M |
| June 30, 2015 | 81.11M |
| March 31, 2015 | 58.33M |
| December 31, 2014 | 52.60M |
| September 30, 2014 | 37.33M |
| June 30, 2014 | 43.20M |
| March 31, 2014 | 43.91M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Incyte Corp. | 5.320B |
| AVITA Medical, Inc. | 61.68M |
| BioCryst Pharmaceuticals, Inc. | 917.38M |
| Neurocrine Biosciences, Inc. | 3.289B |
| Iovance Biotherapeutics, Inc. | 120.66M |